The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy.

The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP ...

The ESC Clinical Consensus Statement offers updated guidance to healthcare professionals on selecting patients for conduction system pacing.  Patient perspective has been incorporated to ensure a ...

AtriCure (NASDAQ:ATRC – Free Report) had its target price decreased by JPMorgan Chase & Co. from $51.00 to $46.00 in a ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced ...

implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries ...

Antitachycardia pacing (ATP) refers to the use of pacing stimulation techniques for termination of tachyarrhythmias. Such techniques can be automatically applied using implantable cardioverter ...

The ASX health sector retreats again with Morgans analyst Scott Power noting various factors putting pressure on the sector ...

AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead ...

LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally ...

Trans cutaneous pacing pads, isoprenaline drip and temporary pacemaker were kept stand-by ... and may lead to decompensation particularly during intrapartum and postpartum period. There can be ...

Sudden cardiac arrest symptoms include sudden loss of consciousness, responsiveness, breathing, and pulse. This may be preceded by dizziness, shortness of breath, a racing heartbeat, or abnormal ...